Jagabandhu Das

3.0k citations

36 papers · 906 indexed · h-index 18

Co-authors: E. J. Corey Marcus A. Tius S. David Kimball Joel C. Barrish Robert V. Moquin Arthur M. Doweyko James C. Lin John Wityak
Topics: Melanoma and MAPK Pathways (7 papers)Chemical Synthesis and Analysis (6 papers)Synthesis and biological activity (4 papers)
Cited by: Organic Chemistry Hematology Toxicology
Journals: Journal of the American Chemical Society Journal of Medicinal Chemistry Protein Science
Partner nations: United States Germany Sweden

In The Last Decade

Jagabandhu Das

36 papers receiving 850 citations

Peers

Countries citing papers authored by Jagabandhu Das

Since Specialization

Citations

This map shows the geographic impact of Jagabandhu Das's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jagabandhu Das with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jagabandhu Das more than expected).

Fields of papers citing papers by Jagabandhu Das

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jagabandhu Das. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jagabandhu Das. The network helps show where Jagabandhu Das may publish in the future.

Co-authorship network of co-authors of Jagabandhu Das

This figure shows the co-authorship network connecting the top 25 collaborators of Jagabandhu Das. A scholar is included among the top collaborators of Jagabandhu Das based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jagabandhu Das. Jagabandhu Das is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	5-Amino-pyrazoles as potent and selective p38α inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das,Robert V. Moquin,Alaric J. Dyckman,Tianle Li,Sidney Pitt,Rosemary Zhang,Ding Ren Shen,Kim W. McIntyre,Kathleen M. Gillooly,Arthur M. Doweyko,John A. Newitt,John S. Sack,Hongjian Zhang,Susan E. Kiefer,Kevin Kish,Murray McKinnon,Joel C. Barrish,John H. Dodd,Gary L. Schieven,Katerina Leftheris	19
2	Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IκB kinase 2009 ·Bioorganic & Medicinal Chemistry Letters ·James Kempson,Junqing Guo,Jagabandhu Das,Robert V. Moquin,Steven H. Spergel,Scott H. Watterson,Charles M. Langevine,Alaric J. Dyckman,Mark A. Pattoli,James R. Burke,Xiao-Xia Yang,Kathleen M. Gillooly,Kim W. McIntyre,(unknown),John H. Dodd,Murray McKinnon,Joel C. Barrish,William J. Pitts	16
3	Pyrazolo-pyrimidines: A novel heterocyclic scaffold for potent and selective p38α inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das,Robert V. Moquin,Sidney Pitt,Rosemary Zhang,Ding Ren Shen,Kim W. McIntyre,Kathleen M. Gillooly,Arthur M. Doweyko,John S. Sack,Hongjian Zhang,Susan E. Kiefer,Kevin Kish,Murray McKinnon,Joel C. Barrish,John H. Dodd,Gary L. Schieven,Katerina Leftheris	37
4	Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das,(unknown),Chunjian Liu,Robert V. Moquin,James C. Lin,Steven H. Spergel,Kim W. McIntyre,David J. Shuster,Kathleen O'Day,Becky Penhallow,(unknown),Arthur M. Doweyko,Amrita V. Kamath,Hongjian Zhang,Punit Marathe,Steven B. Kanner,Tai-An Lin,John H. Dodd,Joel C. Barrish,John Wityak	64
5	Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das,Chunjian Liu,Robert V. Moquin,James C. Lin,(unknown),Steven H. Spergel,Kim W. McIntyre,David J. Shuster,Kathleen O'Day,Becky Penhallow,(unknown),Steven B. Kanner,Tai-An Lin,John H. Dodd,Joel C. Barrish,John Wityak	31
6	Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56Lck inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Ping Chen,Derek Norris,Jagabandhu Das,Steven H. Spergel,John Wityak,Leslie Leith,Rui-Lin Zhao,Bang‐Chi Chen,Sidney Pitt,Suhong Pang,Ding Ren Shen,Rosemary Zhang,H. Fex,Arthur M. Doweyko,Kim W. McIntyre,David J. Shuster,Kamelia Behnia,Gary L. Schieven,Joel C. Barrish	22
7	Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56Lck 2003 ·Bioorganic & Medicinal Chemistry Letters ·John Wityak,Jagabandhu Das,Robert V. Moquin,Zhongqi Shen,James C. Lin,Ping Chen,Arthur M. Doweyko,Sidney Pitt,Suhong Pang,Ding Ren Shen,Qiong Fang,H. Fex,Gary L. Schieven,Steven B. Kanner,Joel C. Barrish	39
8	Discovery of 2-amino-heteroaryl-benzothiazole-6-anilides as potent p56lck inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das,Robert V. Moquin,James C. Lin,Chunjian Liu,Arthur M. Doweyko,(unknown),Qiong Fang,Suhong Pang,Sidney Pitt,Ding Ren Shen,Gary L. Schieven,Joel C. Barrish,John Wityak	92
9	Molecular design, synthesis, and structure–Activity relationships leading to the potent and selective p56lck inhibitor BMS-243117 2003 ·Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das,James C. Lin,Robert V. Moquin,Zhongqi Shen,Steven H. Spergel,John Wityak,Arthur M. Doweyko,(unknown),Qiong Fang,Suhong Pang,Sidney Pitt,Ding Ren Shen,Gary L. Schieven,Joel C. Barrish	47
10	Molecular design and structure–Activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664 2002 ·Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das,S. David Kimball,Steven E. Hall,(unknown),Edwin J. Iwanowicz,James C. Lin,Robert V. Moquin,(unknown),John S. Sack,Mary F. Malley,ChiehYing Y. Chang,Saeho Chong,David Wang‐Iverson,Daniel G. Roberts,Steven M. Seiler,William A. Schumacher,Martin L. Ogletree	10
11	Synthesis and SAR of novel imidazoquinoxaline-Based Lck inhibitors: improvement of cell potency 2002 ·Bioorganic & Medicinal Chemistry Letters ·Ping Chen,Edwin J. Iwanowicz,Derek Norris,Henry H. Gu,James C. Lin,Robert V. Moquin,Jagabandhu Das,John Wityak,Steven H. Spergel,(unknown),Suhong Pang,(unknown),Ding Ren Shen,Gary L. Schieven,Joel C. Barrish	13
12	Crystallographic determination of the structures of human α‐thrombin complexed with BMS‐186282 and BMS‐189090 1996 ·Protein Science ·Mary F. Malley,John S. Sack,Lydia Tabernero,(unknown),(unknown),Daniel G. Roberts,Jagabandhu Das	27
13	Thrombin active site inhibitors 1995 ·Bioorganic & Medicinal Chemistry ·Jagabandhu Das,S. David Kimball	72
14	1-benzazepin-2-one calcium channel blockers—VI. Receptor-binding model and possible relationship to desmethoxyverapamil. 1993 ·Bioorganic & Medicinal Chemistry ·S. David Kimball,John T. Hunt,Joel C. Barrish,Jagabandhu Das,David Floyd,Michael W. Lago,Ving G. Lee,Steven H. Spergel,Suzanne Moreland,(unknown),Jack Z. Gougoutas,Mary F. Malley,(unknown)	11
15	Benzazepinone calcium channel blockers. 5. Effects on antihypertensive activity associated with N1 and aromatic substituents 1992 ·Journal of Medicinal Chemistry ·Jagabandhu Das,David Floyd,S. David Kimball,Keith J. Duff,Michael W. Lago,John Krapcho,Ronald E. White,(unknown),Mary T. Obermeier	13
16	Novel methods for syntheses of substituted oxazoles by cyclization of vinyl bromides 1992 ·Tetrahedron Letters ·Jagabandhu Das,(unknown),David R. Kronenthal,Janak Singh,Paul D. Pansegrau,Richard H. Mueller	26
17	7-Oxabicyclo[2.2.1]heptyl carboxylic acids as thromboxane A2 antagonists: aza .omega.-chain analogs 1990 ·Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),Jagabandhu Das,(unknown),Martin F. Haslanger,(unknown),Don N. Harris,Anders Hedberg,Martin L. Ogletree,Steven E. Hall	17
18	9,11-Epoxy-9-homoprosta-5-enoic acid analogs as thromboxane A2 receptor antagonists 1990 ·Journal of Medicinal Chemistry ·Jagabandhu Das,Steven E. Hall,(unknown),Martin F. Haslanger,(unknown),(unknown),(unknown),Don N. Harris,Anders Hedberg,Martin L. Ogletree	4
19	Synthesis and pharmacological evaluation of 5,6-exo-epoxy-7-oxabicyclo[2.2.1]heptane derivatives 1988 ·Journal of Medicinal Chemistry ·Jagabandhu Das,(unknown),Don N. Harris,Martin L. Ogletree	10
20	A new method for stereospecific cis hydroxylation of olefins 1982 ·Tetrahedron Letters ·E. J. Corey,Jagabandhu Das	24

About Jagabandhu Das

Jagabandhu Das is a scholar working on Organic Chemistry, Pharmaceutical Science and Hematology, having authored 36 papers that have together received 906 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (7 papers), Chemical Synthesis and Analysis (6 papers) and Synthesis and biological activity (4 papers). The work is most often cited by research in Organic Chemistry (588 citations), Hematology (84 citations) and Toxicology (25 citations). Jagabandhu Das has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include E. J. Corey, Marcus A. Tius, S. David Kimball, Joel C. Barrish, Robert V. Moquin, Arthur M. Doweyko, James C. Lin, John Wityak, Ding Ren Shen and Gary L. Schieven. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Protein Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact